Revelation Biosciences, Inc. (NASDAQ:REVB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anthony C. Hayes Other companies: SIM Acquisition Corp. I (Director · Since at least Mar 7, 2026); Dominari Holdings Inc. (CEO & Chairman of the Board · Since at least Sep 10, 2013); Hoth Therapeutics, Inc. (Director · Feb 14, 2019 – Dec 31, 2019 · Past) | Director · Oct 7, 2020 – Oct 7, 2020 · Past |
| George F Tidmarsh Other companies: La Jolla Pharmaceutical Co (President, CEO & Secretary, Director · Jan 19, 2012 – Apr 15, 2019 · Past); Anavex Life Sciences Corp. (Executive Director, Director · Oct 10, 2011 – Feb 9, 2012 · Past); Spectrum Pharmaceuticals Inc (CSO and Head of R&D Operations · Jul 15, 2010 – Jan 3, 2011 · Past) | Director · Jan 10, 2022 – Feb 11, 2025 · Past |
| David Dobkin Other companies: LifeSci Acquisition II Corp (Chief Financial Officer, Director · Nov 20, 2020 – Nov 20, 2020 · Past) | Director · Oct 7, 2020 – Oct 7, 2020 · Past |
| James Rolke Other companies: La Jolla Pharmaceutical Co (Chief Scientific Officer · Jan 1, 2017 – May 29, 2020 · Past) | Chairman, Director and Chief Executive Officer · Since at least Jan 10, 2022 |
| Jennifer Carver Other companies: La Jolla Pharmaceutical Co (Chief Operating Officer · Jan 1, 2016 – Feb 28, 2019 · Past) | Director · Since at least Jan 10, 2022 |
| Jess Roper Other companies: DexCom, Inc. (Former SVP, CFO · Jul 31, 2007 – Apr 1, 2017 · Past) | Director · Since at least Jan 10, 2022 |
| Andreas Typaldos | Chief Executive Officer, Director · Oct 7, 2020 – Dec 30, 2020 · Past |
| Carol Odle | Vice President, Clinical Operations · Since at least Nov 5, 2026 |
| Chester Stanley Zygmont III | Chief Financial Officer · Since at least Jan 10, 2022 |
| Chester Zygmont | Chief Financial Officer · Since at least Aug 18, 2026 |
| Kimon Angelides | Director · Oct 7, 2020 – Oct 7, 2020 · Past |
| Lakhmir Chawla | Director · Since at least Sep 27, 2023 |
| Robert D Nicholson | Director · Oct 7, 2020 – Oct 7, 2020 · Past |
| Robin Marsden | Senior Vice President, Biology · Since at least Jan 14, 2026 |
| Sean H Fitzpatrick | Chief Executive Officer, Director · Oct 7, 2020 – Dec 30, 2020 · Past |
| William Howard Carson | Director · Mar 11, 2021 – Mar 11, 2021 · Past |